GlassScriptPhysician profile
Susan H Ryu
NPI 1346359270
$1,150.41
in general payments reported to CMS, 2019-2025
8 companies · $69.21 in 2025
The $69.21 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2021: $24.89 · 2022: $133 · 2023: $157 · 2024: $474 · 2025: $69.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $374.67 | 2019-2024 | Omni Surgical System |
| Alcon Vision LLC | $310.63 | 2019-2025 | Hydrus Microstent, Rocklatan |
| Aerie Pharmaceuticals, INC. | $147.99 | 2019 | |
| Mallinckrodt Hospital Products INC. | $146.20 | 2024 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $57.25 | 2023-2024 | Tecnis Iol, Tecnis Simplicity, Veritas Vision System |
| Allergan, INC. | $49.71 | 2019 | |
| Genentech, INC. | $35.26 | 2023 | Susvimo, Vabysmo |
| Mallinckrodt Enterprises LLC | $28.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Ryu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.